Ampio Pharma (AMPE) Enters Exclusive Zertane License Agreement with FMBFarma

Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE) and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane™ in Brazil for the treatment of premature ejaculation (PE). Financial terms were not disclosed at the request of FBMFarma, who will be responsible for obtaining regulatory approval, marketing and distribution in Brazil.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Sky Quarry names Heidi Bowman as CFO
• Greenland approves rare earths license transfer to Greenland Mines
• Walmart opens its 100th EV fast-charging site in Monument, CO